ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Web Header
Advertisement
Home / Education And Resources / Clinical Practice Treatment / Treatment / Immunotherapy

IMMUNOTHERAPY

As immunotherapy for cancer continues to evolve—so has the Association of Cancer Care Centers—adapting to meet the changing needs of the oncology community.


The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.


Under the guidance of the IO Institute Executive Committee, multispecialty Working Groups were established to focus on Big Data, Telemedicine, Care Coordination and Communication, and Training and Education. IO Working Groups members share their expertise, knowledge, and forward-looking perspectives to provide a framework for developing proactive strategies for effective delivery of these new and emerging therapies.


For more information on this project, please contact the ACCC Provider Education department.

Featured Program

Optimizing Outcomes for Patients with Urothelial Carcinoma

View Now

Overcoming Obstacles in Integrating Immunotherapies for Cancer in the Community Setting

View Now

Best Practices for Implementing Cancer Immunotherapy in the Community Overview

View Now

The Evolving Immunotherapeutic Landscape in Renal Cell Carcinoma

View Now

Survivorship in the Era of 10

View Now

Preparing for New Cellular Therapies: Tumor-Infiltrating Lymphocytes

View Now

Managing Immune-Related Adverse Events

View Now

Elevating Survivorship

View Now

Effective Practices For Optimizing Care Coordination and Delivery of CAR T-Cell Therapy Across Care Settings

View Now

Preparing Community Providers for Bispecific Antibodies

View Now

Featured Resources

Foundations of Bispecific Antibodies (BsAbs)

This educational recording reviews the basics of bispecific antibodies, their clinical applications, and FDA-approved treatments. It also provides practical strategies for managing adverse events, patient education and the financial and operational factors essential for successful integration into clinical practice.

Access Now

Remote Patient Monitoring in Oncology: Best Practices for Managing Immune-Related Adverse Events

This guide offers an 8-step framework for implementing remote patient monitoring (RPM) programs, empowering providers to detect and manage irAEs for timely interventions, enhancing patient outcomes and quality of life.

Access Now

Featured Publications

Immuno-Oncology in 2021: Committed to the Cutting Edge of Care

Download
Immuno-Oncology in 2021: Committed to the Cutting Edge of Care

On-Demand Webinars

Optimizing Treatment with Molecular Tumor Boards

Learn from experts Derek B. Allison, MD, and Justine C. Pickarski, MS, LGC, about how they developed Markey Cancer Center’s statewide molecular tumor board as well as lessons learned and key takeaways.

View Now

News & Media

ACCC Releases Annual Report on Current State of Immuno-Oncology

The ASCO Post
Sep 10th 2021

Community Oncology Professionals Highlight Need for More Education on Immunotherapies

Targeted Oncology
Aug 11th 2021

ACCC Report: Immunotherapy Research Grew in 2020 Despite COVID-19 Pandemic

OncLive
Aug 7th 2021

ACCC Survey Reveals Biggest Challenges and Concerns Regarding IO Therapies

AJMC
Aug 4th 2021

ACCC Immuno-Oncology Institute Releases Report on the State of Immuno-Oncology

Jun 29th 2020

Where Does Survivorship Stand in the Era of Immuno-Oncology?

Oncology Times
Jan 5th 2020

Improving Immunotherapy Implementation in Community Practice

Oncology Nursing News
Jun 17th 2019

An Evidence-Based Argument Is Often the Fastest Route to Immunotherapy Authorization

OncLive
Apr 30th 2019

Telemedicine working group aims to address ‘big gaps’ of emergency cancer care

HemOnc Today
Apr 25th 2019

From the ACCCBuzz Blog

Light Bulb Idea with Collaboration_ACCCBuzz_Square

Addressing Cardiovascular Complications in Cancer Immunotherapy: A Guide for Providers

Jun 20th 2024

Explore the role of cardio-oncology in understanding and managing potential cardiovascular complications of immune checkpoint inhibitors.

Immunotherapy_ACCCBuzz_Square

A Progress Report on Cancer Immunotherapy

Jun 17th 2024

ACCCBuzz recognizes June as Cancer Immunotherapy Month.

Quality Improvement_ACCCBuzz_Square

Collaborative Care: Implementing an Innovative Digital Tool

Apr 29th 2024

ACCC recently announced a collaboration with the Digital Medicine Society on a project to develop a risk prediction tool for cytokine release syndrome.

Immunotherapy_ACCCBuzz_Square

Early Identification and Management of Pneumonitis and Other irAEs in Patients with NSCLC

Sep 1st 2023

As immune checkpoint inhibitors have become the standard of care for eligible patients with NSCLC, frequent monitoring of irAEs as well as provider and patient education on the signs and symptoms of pneumonitis can ensure improved clinical outcomes for patients.

Concept of Teamwork_ACCCBuzz_Square

The Role of a Pharmacist in Managing irAEs

Aug 17th 2023

Managing immunotherapy related adverse events (irAEs) requires a team-based effort, with pharmacists playing an integral role in their identification and management within both outpatient and inpatient multidisciplinary teams.

Immunotherapy_ACCCBuzz_Square

A New Decade for Advancements in Immunotherapy

Jun 8th 2023

June is Cancer Immunotherapy Month, and ACCC is highlighting the important work that it and its partners are doing to increase patient access to these novel therapies.

More Immunotherapy Blog Posts

Abstracts & Presentations

Trends in immune-related adverse event reporting among multidisciplinary cancer programs.

ASCO